Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Huoxue Shugan Bushen is a Traditional Chinese Medicine (TCM) herbal formula investigated for its therapeutic potential in treating postoperative infertility associated with endometriosis. The formula's name is derived from its primary TCM therapeutic actions: *Huoxue* (promoting blood circulation to resolve stasis), *Shugan* (soothing the liver to regulate qi), and *Bushen* (tonifying the kidney to support reproductive health). Developed and studied by researchers at Guang'anmen Hospital, the formula is typically administered orally as a decoction or granules. It is hypothesized to improve the pelvic microenvironment, enhance endometrial receptivity, and reduce the recurrence of endometriotic lesions following surgical intervention, thereby improving pregnancy outcomes in affected women.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on huoxue shugan bushen.